{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Asheville",
      "state": "NC",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80601",
      "recalling_firm": "King Bio Inc.",
      "address_1": "3 Westside Dr",
      "address_2": "N/A",
      "postal_code": "28806-2846",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.",
      "recall_number": "D-0719-2019",
      "product_description": "Dr. King's SafeCare Rx GallPlex, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955006824, NDC 57955-0340-2",
      "product_quantity": "217 bottles",
      "reason_for_recall": "Microbial contamination",
      "recall_initiation_date": "20180720",
      "center_classification_date": "20190308",
      "termination_date": "20220119",
      "report_date": "20190320",
      "code_info": "Lots: 110916A Exp. 11/19; 011518B Exp. 01/20"
    }
  ]
}